HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,775,233 | -7.3% | 220,755 | -11.9% | 0.05% | -5.6% |
| Q2 2023 | $21,332,253 | -8.6% | 250,555 | -11.1% | 0.05% | -10.0% |
| Q1 2023 | $23,331,776 | -3.2% | 281,955 | -8.0% | 0.06% | -10.4% |
| Q4 2022 | $24,102,686 | -6.0% | 306,455 | -11.5% | 0.07% | -9.5% |
| Q3 2022 | $25,648,000 | -4.3% | 346,455 | -15.8% | 0.07% | -2.6% |
| Q2 2022 | $26,812,000 | +2.1% | 411,355 | -1.0% | 0.08% | +8.6% |
| Q1 2022 | $26,271,000 | +64.9% | 415,555 | +38.3% | 0.07% | +75.0% |
| Q4 2021 | $15,936,000 | -23.9% | 300,455 | +1.3% | 0.04% | -25.9% |
| Q3 2021 | $20,934,000 | +202.2% | 296,555 | +185.3% | 0.05% | +200.0% |
| Q2 2021 | $6,928,000 | -63.0% | 103,955 | -38.3% | 0.02% | -64.7% |
| Q1 2021 | $18,700,000 | -41.6% | 168,455 | -37.6% | 0.05% | -40.7% |
| Q4 2020 | $32,033,000 | -27.5% | 269,755 | -46.7% | 0.09% | -31.7% |
| Q3 2020 | $44,188,000 | +73.5% | 506,455 | +78.1% | 0.13% | +68.0% |
| Q2 2020 | $25,467,000 | +35.5% | 284,355 | +50.8% | 0.08% | +4.2% |
| Q1 2020 | $18,791,000 | -8.6% | 188,555 | +5.4% | 0.07% | +50.0% |
| Q4 2019 | $20,562,000 | +16.8% | 178,955 | +28.2% | 0.05% | +11.6% |
| Q3 2019 | $17,603,000 | -0.0% | 139,555 | -4.6% | 0.04% | -2.3% |
| Q2 2019 | $17,606,000 | +15.3% | 146,300 | -16.2% | 0.04% | +12.8% |
| Q1 2019 | $15,270,000 | -0.7% | 174,555 | +13.6% | 0.04% | -7.1% |
| Q4 2018 | $15,378,000 | -17.1% | 153,700 | -5.1% | 0.04% | -6.7% |
| Q3 2018 | $18,551,000 | +5.5% | 161,905 | -17.5% | 0.04% | -4.3% |
| Q2 2018 | $17,592,000 | +56.0% | 196,160 | +27.3% | 0.05% | +51.6% |
| Q1 2018 | $11,274,000 | -38.0% | 154,100 | -50.8% | 0.03% | -36.7% |
| Q4 2017 | $18,197,000 | +331.4% | 313,305 | +233.3% | 0.05% | +308.3% |
| Q3 2017 | $4,218,000 | +17.9% | 94,005 | +3.8% | 0.01% | 0.0% |
| Q2 2017 | $3,578,000 | +7.0% | 90,600 | +10.0% | 0.01% | +9.1% |
| Q1 2017 | $3,343,000 | +66.7% | 82,400 | +65.1% | 0.01% | +37.5% |
| Q4 2016 | $2,006,000 | +287.3% | 49,900 | +248.8% | 0.01% | +300.0% |
| Q3 2016 | $518,000 | +155.2% | 14,305 | +146.4% | 0.00% | +100.0% |
| Q1 2016 | $203,000 | -95.4% | 5,805 | -95.3% | 0.00% | -97.1% |
| Q2 2014 | $4,375,000 | +34.0% | 124,005 | +23.8% | 0.03% | +13.3% |
| Q1 2014 | $3,266,000 | – | 100,205 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |